Datasets
Buyer room
FLATIRON.COMManage supplier listing
Flatiron Health (a Roche company) — Research-ready, de-identified longitudinal real-world oncology data derived from partner health systems' EHRs — 15+ years of longitudinal data across 22+ tumor types and 6M+ patients, used for benchmarking, quality improvement, and research.. ~1,600 employees (Apollo); $2.2B total funding (Apollo, reflecting Roche's majority investment); $375.5M revenue range; 6M+ patient records, 22+ tumor types, 2,000+ peer-reviewed publications powered by Flatiron data, 45+ global regulatory decisions informed (stated on page).. Use cases: Publishing high-impact oncology…
Research-ready, de-identified longitudinal real-world oncology data derived from partner health systems' EHRs — 15+ years of longitudinal data across 22+ tumor types and 6M+ patients, used for benchmarking, quality improvement, and research.
Scale 6M+ patient records across 22+ tumor typesFrom 15 yearsCoverage Health Care
Sample, licence terms, pricing and eval results when Flatiron publishes them. Until then, discover alternatives today with a 7-day trial.
Start 7-day trial →What buyers ask about Flatiron, answered from this page.
Flatiron Health (a Roche company) — Research-ready, de-identified longitudinal real-world oncology data derived from partner health systems' EHRs — 15+ years of longitudinal data across 22+ tumor types and 6M+ patients, used for benchmarking, quality improvement, and research.. ~1,600 employees (Apollo); $2.2B total funding (Apollo, reflecting Roche's majority investment); $375.5M revenue range; 6M+ patient records, 22+ tumor types, 2,000+ peer-reviewed publications powered by Flatiron data, 45+ global regulatory decisions informed (stated on page).. Use cases: Publishing high-impact oncology…
Flatiron offers (Alternative, Fundamental) — 6M+ patient records across 22+ tumor types; 2,000+ peer-reviewed publications and 45+ global regulatory decisions informed by the underlying data (stated on page)..
Publishing high-impact oncology research, benchmarking care across health systems, quality-improvement initiatives, feasibility analysis for trials, investigator-initiated studies, rare-cohort research.
The data is with 15 years of history.
Coverage spans Other; Life Sciences Tools & Services; alternative, fundamental; equities.
Flatiron has not added their own details yet. Not yet on file: